Machine learning model designed to measure sepsis risk

An AI-based sepsis screening tool could better help physicians find patients most at risk of developing the illness after it outperformed other traditional screening methods, according to a study published in the Annals of Emergency Medicine.

Several healthcare organizations in the United States and United Kingdom have turned to AI solutions to address sepsis in patients and prevent fatal outcomes. Last November, Massachusetts researchers developed an AI system that predicted when critical drugs should be administered to sepsis patients.

For this study, a research team used machine learning to develop and test a sepsis screening tool—called the Risk of Sepsis Score (RoS)—with electronic health record data from emergency room (ER) patients at 49 different urban community hospitals. The data featured about 2.7 million records.

The screening method was analyzed one, three, six, 12 and 24 hours after receiving the data. Additionally, its performance was rated with various metrics—alert rate, area under the receiver operating characteristic curve (AUC), sensitivity, specificity and precision. According to the study, the RoS was the “most discriminant screening tool” when identifying most at-risk patients, and was significantly more sensitive and precise than the next top performing sepsis screening method.

“In this retrospective study, RoS was more timely and discriminant than benchmark screening tools...further study is needed to validate the RoS score at independent sites,” Ryan J. Delahanty, PhD, data scientist at Tenet Healthcare, et al. concluded.

""

Danielle covers Clinical Innovation & Technology as a senior news writer for TriMed Media. Previously, she worked as a news reporter in northeast Missouri and earned a journalism degree from the University of Illinois at Urbana-Champaign. She's also a huge fan of the Chicago Cubs, Bears and Bulls. 

Around the web

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”